课题基金 / 基金详情

BIOLOGIC EFFECTS OF PERTUSSIS ADENYLATE CYCLASE

BIOLOGIC EFFECTS OF PERTUSSIS ADENYLATE CYCLASE
百日咳腺苷酸环化酶的生物学作用
批准号:
3128234
负责人:
JOHN W EATON
金额:
$6.92万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1983
资助国家:
美国
项目状态:
已结题
起止时间:
1983-01-01 至 1985-12-31

项目摘要

项目成果

JOHN W EATON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
All successful pathogens have evolved strategies which allow survival and replication within the potentially hostile environment of the host. In many cases, the strategies are aimed at avoidance of destruction by host phagocytes. This application concerns a unique device employed by Bordetella spp. for paralyzing phagocytic cells. B. pertussis (and other species of Bordetella) elaborates a soluble and highly active adenylate cyclase. We have found that this enzyme will cause intact mammalian cells to accumulate large quantities of cyclic AMP, probably as a result of internalization. The cyclic AMP, in turn, disarms phagocyte bacteriocidal processes. This unusual phagocyte avoidance strategy may explain several of the peculiar characteristics of Bordetella infections, including the lack of activated oxygen production by alveolar macrophages derived from Bordetella-infected animals and the greatly enhanced susceptibility of Bordetella infected humans to secondary infections. If the bacterial cyclase also penetrates pulmonary cells, then greatly elevated cyclic AMP may cause the ciliary dysfunction evident in victims of B. pertussis infection. The research proposed in this application is aimed at further elucidation of the cellular effects of Brodetella-induced elevations of host cell cyclic AMP levels. We shall also explore the possibility that B. pertussis adenylate cyclase might be used in the purposeful modulation of a variety of cellular functions. The results of these studies should help elucidate the pathogenesis of B. pertussis infection and may provide a very useful tool for the artificial manipulation of cellular cyclic AMP concentrations. In view of the great number of drugs which act through modulation of cyclic AMP metabolism, the use of this bacterial enzyme may represent a novel and potentially powerful mode of pharmacologic manipulation of many cellular functions.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/s0021-9258(17)42604-4
发表时间: 1984-12
期刊: The Journal of biological chemistry
影响因子: --
作者: [S. Sadrzadeh;E. Graf;S. Panter;P. E. Hallaway;J. Eaton]
通讯作者: S. Sadrzadeh;E. Graf;S. Panter;P. E. Hallaway;J. Eaton
DOI: 10.1016/s0021-9258(17)43139-5
发表时间: 1984-03
期刊: The Journal of biological chemistry
影响因子: --
作者: [E. Graf;J. Mahoney;R. Bryant;J. Eaton]
通讯作者: E. Graf;J. Mahoney;R. Bryant;J. Eaton
Bordetella adenylate cyclase toxin: entry of bacterial adenylate cyclase into mammalian cells.
博德特氏菌腺苷酸环化酶毒素:细菌腺苷酸环化酶进入哺乳动物细胞。
DOI: --
发表时间: 1984
期刊: Advances in cyclic nucleotide and protein phosphorylation research
影响因子: --
作者: [Confer,DL, Slungaard,AS, Graf,E, Panter,SS, Eaton,JW]
通讯作者: Eaton,JW
VASCULAR IRON DEPOSITION & DIABETIC COMPLICATIONS
  • 批准号:
    6118861
  • 项目类别:
  • 资助金额:
    $0.49万
  • 财政年份:
    1999
  • 负责人:
    JOHN W EATON
  • 依托单位:
BIOMATERIAL MEDIATED INFLAMMATION AND FIBROSIS
  • 批准号:
    6440192
  • 项目类别:
  • 资助金额:
    $26.16万
  • 财政年份:
    1997
  • 负责人:
    JOHN W EATON
  • 依托单位:
BIOMATERIAL MEDIATED INFLAMMATION AND FIBROSIS
  • 批准号:
    6389763
  • 项目类别:
  • 资助金额:
    $25.2万
  • 财政年份:
    1997
  • 负责人:
    JOHN W EATON
  • 依托单位:
BIOMATERIAL MEDIATED INFLAMMATION AND FIBROSIS
  • 批准号:
    6682870
  • 项目类别:
  • 资助金额:
    $25.2万
  • 财政年份:
    1997
  • 负责人:
    JOHN W EATON
  • 依托单位:
国内基金
海外基金
asr基因调控酸诱导的Escherichia coli O157:H7形成VBNC状态的机制研究
  • 批准号:
    32302245
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    潘寒姁
  • 依托单位:
小肠中Escherichia coli分泌细菌毒素诱导肠屏障损伤及细菌易位在炎症性肠病中的机制研究
  • 批准号:
    82371775
  • 项目类别:
    面上项目
  • 资助金额:
    46万元
  • 批准年份:
    2023
  • 负责人:
    朱慧媛
  • 依托单位:
基于Escherichia coli O157:H7亚致死态细胞探究超高压与原儿茶酸协同杀菌机制
  • 批准号:
    31871817
  • 项目类别:
    面上项目
  • 资助金额:
    60.0万元
  • 批准年份:
    2018
  • 负责人:
    孙爱东
  • 依托单位:
肠肝轴:从临床患者分离的肠道致病菌株Escherichia coli NF73-1对非酒精性脂肪性肝病的作用及机制研究
  • 批准号:
    81873549
  • 项目类别:
    面上项目
  • 资助金额:
    57.0万元
  • 批准年份:
    2018
  • 负责人:
    刘玉兰
  • 依托单位: